Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksX5 Retail Regulatory News (FIVE)

  • This share is currently suspended. It was suspended at a price of 0.5314

Share Price Information for X5 Retail (FIVE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.5314
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.5314
FIVE Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

X5 AND SANTENS TO CREATE PHARMA MARKETPLACE

19 Jun 2019 08:00

RNS Number : 6607C
X5 Retail Group N.V.
19 June 2019
 

X5 AND SANTENS TO CREATE PHARMA MARKETPLACE

Moscow, 19 June 2019 - X5 Retail Group N.V. ("X5" or the "Company"), a leading Russian food retailer (LSE and MOEX ticker: "FIVE"), announces a partnership involving X5 subsidiary OMNI, Perekrestok Online and Santens Service Group. The parties have agreed to join forces in an effort to develop a pharmaceutical marketplace based on the Perekrestok.ru online store.

As part of the project, a special section of Perekrestok.ru will be devoted to products from pharmaceuticals producers: apteka.perekrestok.ru. This will benefit customers, who will gain the ability to order medicines directly from manufacturers. Orders can be paid for and collected at pharmacy pick-up points in X5 retail stores. X5 OMNI, which is developing the Company's technology platform for parcel delivery, has already made arrangements to open 1,400 pharmacy pick-up points at X5 stores. Santens will handle the supply chain logistics to ensure delivery to pick-up points.

Andrey Osipov, Santens Logistics Group CEO, said: "Under the agreement, we will provide an extended range of services to pharmaceuticals producers, including potentially full supply chain management, while using X5's extensive retail network to make medicines more affordable for consumers and improve their quality of life. Our partnership seeks to facilitate consumer access to medicines and reduce treatment costs by introducing a fundamentally new supply chain model for delivering pharmaceuticals from manufacturers to patients."

Leonid Dovladbegyan, Director for Strategy and E-commerce Development at Perekrestok supermarkets said: "For us, the partnership with Santens is a strategic move given the role that Perekrestok.ru plays in our efforts to expand the range of products available to our customers. The share of online shopping in the pharmacy segment is rising, and our customers are increasingly looking for specific medicines. We are interested in having the product range offered by Russia's leading pharmaceuticals operator in our online store, without having to invest in logistics infrastructure: Santens will be responsible for processing, assembling, sorting and delivering orders to pharmacy pick-up points at X5 retail stores."

Igor Pletnev, Director for Strategic Business Development at X5 Retail Group, said: "This partnership agreement is an important milestone in the development of X5 OMNI's technology platform for parcel delivery. By teaming up with Santens we are adding a new category, medicines, to our product mix. Essentially, Perekrestok.ru is providing a ground-breaking service to partners by enabling direct access to end consumers and providing an opportunity to bypass the existing supply chain dominated by intermediaries and lacking efficiency and transparency."

 

 

 

 

 

 

Note to Editors:

X5 Retail Group N.V. (LSE and MOEX: FIVE, Fitch - 'BB+', Moody's - 'Ba1', S&P - 'BB', RAEX - 'ruAA') is a leading Russian food retailer. The Company operates several retail formats: the chain of proximity stores under the Pyaterochka brand, the supermarket chain under the Perekrestok brand and the hypermarket chain under the Karusel brand.

As of 31 March 2019, X5 had 14,779 Company-operated stores. It has the leading market position in both Moscow and St Petersburg and a significant presence in the European part of Russia. Its store base includes 13,917 Pyaterochka proximity stores, 771 Perekrestok supermarkets and 91 Karusel hypermarkets. The Company operates 41 DCs and 3,837 Company-owned trucks across the Russian Federation.

For the full year 2018, revenue totalled RUB 1,532,537 mln (USD 24,439 mln), Adjusted EBITDA reached RUB 109,871 mln (USD 1,752 mln), and net profit for the period amounted to RUB 28,642 mln (USD 457 mln). In Q1 2019, revenue totalled RUB 405,864 mln (USD 6,138 mln), adjusted EBITDA reached RUB 29,473 mln (USD 446 mln), and net profit amounted to RUB 9,297 mln (USD 141 mln).

X5's Shareholder structure is as follows: CTF Holdings S.A. - 47.86%, Intertrust Trustees Ltd (Axon Trust) - 11.43%, X5 Directors - 0.07%, treasury shares - 0.02%, Shareholders with less than 3% - 40.62%.

Santens Service Group is Russia's No. 1 pharma operator, providing customs clearance and logistics services since 2000. Among the company's customers are 40 leading manufacturers of pharma and parapharmaceutical products, medical devices and products, as well as distributors and pharmacy chains. Santens operates eight warehouse facilities with a total capacity of over 150,000 pallet positions and handles over RUB 260 bn worth of pharmaceuticals annually.

Forward looking statements:

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the fact that they do not only relate to historical or current events. Forward-looking statements often use words such as "anticipate", "target", "expect", "estimate", "intend", "expected", "plan", "goal", "believe", or other words of similar meaning.

By their nature, forward-looking statements involve risk and uncertainty because they relate to future events and circumstances, a number of which are beyond X5 Retail Group N.V.'s control. As a result, actual future results may differ materially from the plans, goals and expectations set out in these forward-looking statements.

Any forward-looking statements made by or on behalf of X5 Retail Group N.V. speak only as of the date of this announcement. Save as required by any applicable laws or regulations, X5 Retail Group N.V. undertakes no obligation publicly to release the results of any revisions to any forward-looking statements in this document that may occur due to any change in its expectations or to reflect events or circumstances after the date of this document.

Elements of this press release contain or may contain inside information about X5 Retail Group N.V. within the meaning of Article 7(1) of the Market Abuse Regulation (596/2014/EU).

For further details please contact:

Natalia Zagvozdina

Head of Corporate Finance and IR

Tel.:+7 (495) 662-88-88 ext. 27-300

e-mail: Natalia.Zagvozdina@x5.ru

Andrey Vasin

Head of Investor Relations

Tel.:+7 (495) 662-88-88 ext. 13-151

e-mail: Andrey.Vasin@x5.ru

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKFDBQBKDCAD
Date   Source Headline
29th Jan 200710:43 amRNSStatement re. Press Comment
18th Jan 20077:02 amRNSQ4 2006 trading update
22nd Nov 20067:09 amRNSGDR Purchase Program
21st Nov 20067:08 amRNSAcquisition
13th Nov 20068:48 amRNSGDR purchase
3rd Nov 20067:54 amRNSNew Chairman of the Board
3rd Nov 20067:53 amRNS3rd Quarter Results
3rd Nov 20067:51 amRNS1st Half 2006 audited results
27th Oct 20067:14 amRNSChange of Name
26th Oct 200611:28 amRNSStatement re. Press Comment
18th Oct 20067:00 amRNSChairman of the Board change
17th Oct 20067:00 amRNSEGM Statement
13th Oct 20067:01 amRNSAcquisition
10th Oct 20063:19 pmRNSTrading Statement-Replacement
10th Oct 20067:00 amRNSTrading Statement
3rd Oct 20069:18 amRNSDirector/PDMR Shareholding
26th Sep 20067:46 amRNSNotice of EGM
22nd Sep 20067:01 amRNSCompany Statement
11th Sep 20067:16 amRNSManagement Appointments
4th Sep 20067:57 amRNSInterim Results - Replacement
4th Sep 20067:03 amRNSInterim Results
25th Aug 20067:01 amRNSCredit Rating Update
21st Aug 200612:20 pmRNSManagement Appointments
10th Aug 20067:19 amRNSGDR Purchase Programme Update
8th Aug 20068:36 amRNSRebranding Update
8th Aug 20068:34 amRNSRating Update
2nd Aug 20067:00 amRNSGDR Purchase programme update
27th Jul 20067:00 amRNSGDR Purchase
26th Jul 20067:01 amRNSGDR Purchase Programme Update
18th Jul 20067:01 amRNSGDR Purchase Programme Update
14th Jul 20067:13 amRNSGDR Purchase Programme Update
13th Jul 20067:01 amRNSGDR Purchase Programme Update
10th Jul 20067:01 amRNSQ2 2006 Trading Update
3rd Jul 20069:16 amRNSTrading Statement
30th Jun 20067:03 amRNSGDR Purchase Programme
19th Jun 20063:40 pmRNSPrice Monitoring Extension
15th Jun 20067:02 amRNSTerm Loan Credit Facility
31st May 20068:21 amRNSAnnual Report and Accounts
31st May 20067:13 amRNS1st Quarter Results
31st May 20067:00 amRNSTerm Loan Credit Facility
18th May 20065:14 pmRNSCompletion of Transaction
12th May 20062:09 pmRNSEGM Statement
18th Apr 20067:21 amRNSFinal Results
12th Apr 20067:00 amRNSMerger with Perekriostok
6th Apr 20067:46 amRNSCompany Statement
8th Feb 20067:01 amRNSJanuary 2006 Sales Update
6th Feb 20067:20 amRNSCredit Rating
23rd Jan 20063:19 pmRNSCredit Rating
18th Jan 20067:11 amRNSAcquisition
12th Jan 20067:03 amRNSFY 2005 Sales

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.